$32.39 +0.68 (2.14%)

Azenta, Inc. (AZTA)

Azenta, Inc. (AZTA) is a global provider of life science and laboratory automation solutions. The company specializes in research and development services, sample management, and laboratory products, supporting the pharmaceutical, biotech, and healthcare industries. Azenta focuses on enabling scientific discovery through innovative technology and streamlined workflows.

Dividend Yield 1.23%
Payout Frequency Quarterly

Dividend History

Pay DateAmountEx-DateRecord Date
December 23, 2021$0.102021-12-022021-12-03
September 24, 2021$0.102021-09-022021-09-03
June 25, 2021$0.102021-06-032021-06-04
March 26, 2021$0.102021-03-042021-03-05
December 17, 2020$0.102020-12-032020-12-04

Dividends Summary

Company News

Global Biopreservation Market Set to Surpass USD 7.1 Billion by 2029 | MarketsandMarkets™
GlobeNewswire Inc. • Marketsandmarkets • October 8, 2025

The biopreservation market is experiencing significant growth driven by healthcare expenditure, research investment, and regenerative medicine, with North America leading and Asia Pacific showing fastest potential expansion. Key challenges include storage logistics and sample transportation standards.

Biobanking Market to Reach Market Valuation of USD 95.5 Billion by 2031 | SkyQuest Technology
Benzinga • Globe Newswire • November 14, 2024

The global biobanking market is projected to reach a valuation of USD 95.5 billion by 2031, growing at a CAGR of 6.8% during the forecast period. The growth is driven by the rising demand for personalized medicine, improvements in genomic research, and the high incidence of chronic illnesses worldwide.

Hyperfine (HYPR) to Release ACTION PMR Study Data for Swoop - Zacks Investment Research
Zacks Investment Research • N/A • July 16, 2024

Hyperfine's Swoop system has shown promising results in a study on its ability to quickly assess stroke patients and guide treatment decisions. The study, part of the larger ACTION PMR study, found the Swoop system to be a reliable tool for enabling critical stroke treatment choices in urgent care settings.

S&P 500, Nasdaq post best day since April as subdued inflation reading sparks buying frenzy
MarketWatch • MarketWatch • November 14, 2023

U.S. stocks closed sharply higher Tuesday, after a subdued October inflation reading reinforced expectations the Federal Reserve is finished raising interest rates

You Can't Control Activist Investors, but You Can Control What You Do About Them
The Motley Fool [email protected] (Reuben Gregg Brewer) • October 12, 2023

Activist investors come after companies both big and small, usually looking to get management to change their ways.